Inactive

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulat... This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2061522 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-04, Effective 01/19/2021. The North American Industry Classification System (NAICS) code for this procurement is 325413, in-vitro diagnostic substance manufacturing, with a small business size standard of 1250 employees. This requirement is NOT set-aside for small business. Background: The Vaccine Research Center is developing vaccines for 2019-nCoV, RSV, Influenza, Nipah, HKU1 and other viruses. Production and testing of various wild type and mutant viral proteins and anti-viral antibodies is critical for vaccine development. The goal of the VRC is to translate basic research into concrete vaccine products that can be rapidly deployed to protect public health. These consumables are made to be used with the Octet Machine we purchased from Sartorius. This machine allows us to assess antibodies and immunogens involved in active immunization studies and passive protection studies in a high-throughput manner with high reproducibility and reliability Description and purpose of the Requirement: These requested items are consumables for the Octet machine we purchased from Sartorius. The Biosensors will be used for antigenicity and/or binding analysis. These biosensors have been used to measure protein-protein interactions. SA - Streptavidin (SA) Biosensors - Twenty trays of 96 biosensors coated with streptavidin for quantitation, screening, or kinetic applications. Cat#18-5021-Qty 1 HIS1K - Anti-Penta-HIS (HIS1K) Biosensors - Twenty trays of 96 biosensors coated with the Qiagen Penta-HIS antibody for quantitation and kinetics applications. 20% Discount on 18-5122-Qty 1 Shipping costs if applicable ALL OFFERORS MUST ALSO COMPLETE AND SIGN THE ATTACHED CERTIFICATION (VENDOR CERTIFICATION) Place of Performance: 9 West Watkins Mill Road, Gaithersburg, MD 20878 Delivery Date: 30 Days ARO *Please include your DUNS number on quote *Include response to FAR 52.204-26 and 52.204-24 and return with quote Submission shall be received not later than 10:00 a.m. EST, Friday, February 19, 2021. The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: price, capability to meet the requirements, delivery and the best value to the government. The following FAR provisions apply to this acquisition: FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Oct 2020) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-1 Instructions to Offerors Commercial Items (Jun 2020) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Jan 2021) Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (Jan 2017) The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (Oct 2018) FAR 52-212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Jan 2021) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.203-19 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (Jan 2017) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-19 Incorporation by Reference of Representations and Certifications (Dec 2014) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020) By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Offers may be mailed, e-mailed or faxed to Ms. Lorena Waller, (E-Mail/ Wallerlor@niaid@nih.gov 240-669-5099). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) (Oct 2018) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Ms. Lorena Waller at Wallerlor@niaid.nih.gov.